Antiviral pharmaceutical for topical administration
An enzymatically-active ribonuclease is combined with a vehicle that does not unacceptably interfere with such enzymatic activity and applied externally. Advantageously, the ribonuclease is ranpirnase. The vehicle can be a liquid, a gel, an ointment, or a serum, and can also be an approved sexual lubricant.
1. A topical pharmaceutical composition consisting essentially of a therapeutically effective amount of an enzymatically-active ribonuclease and a viscous vehicle that does not unacceptably interfere with the enzymatic activity, wherein the vehicle is selected from the group consisting of a gel, a serum, or a lotion.
2. The pharmaceutical composition of claim 1 , wherein the enzymatically-active ribonuclease is ranpirnase.
3. The pharmaceutical composition of claim 2 , wherein the pharmaceutical contains between 1 and 3 mg of ranpirnase per ml of vehicle.
4. The pharmaceutical composition of claim 2 , wherein the concentration of ranpirnase in the pharmaceutical composition is chosen to deliver between 1 and 3 mg of ranpirnase to the patient each week that the pharmaceutical composition is administered to the patient in accordance with the dosage regimen used.
5. The pharmaceutical composition of claim 1 , wherein the vehicle is compatible with latex condoms.
6. The pharmaceutical composition of claim 1 , wherein the vehicle is an aqueous vehicle.
7. The pharmaceutical composition of claim 6 , wherein the vehicle is an approved sexual lubricant.